Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for COVID-19 Post-Exposure Prophylaxis
NCT04597775Phase 3Unknown
- Sponsor
- Regional Center for Disease Control and Prevention
- Start
- Oct 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by Regional Center for Disease Control and Prevention. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04597775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04597775.